3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, T-Cell
5
Recurrence
2
Lymphoma, T-Cell, Peripheral
2
Lymphoma
2
Immunoblastic Lymphadenopathy
2
Sezary Syndrome
1
Mycosis Fungoides
1
Lymphoma, Large-Cell, Anaplastic
1
Leukemia, Prolymphocytic, T-Cell
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, Large Granular Lymphocytic
1
Enteropathy-Associated T-Cell Lymphoma
1
Interventions
Rituximab
27
Lenalidomide
22
Cyclophosphamide
20
Prednisone
14
Vincristine
12
obinutuzumab
11
Magnetic Resonance Spectroscopy
11
Doxorubicin
11
Specimen Handling
9
Bendamustine Hydrochloride
8
ibrutinib
7
Biopsy
7
pembrolizumab
6
fludarabine
6
fludarabine phosphate
5
Radiotherapy
5
Peripheral Blood Stem Cell Transplantation
5
zanubrutinib
4
venetoclax
4
tazemetostat
4
Whole-Body Irradiation
4
R-CHOP protocol
4
Etoposide
4
CT-P10
4
Prednisolone
3
Mycophenolic Acid
3
Cyclosporine
3
tisagenlecleucel
2
polatuzumab vedotin
2
orelabrutinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Follicular
×
duvelisib
×
90 days
×
Clear all
No trials found.